Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	177.13	58.47	21.10
Graham Fair Price	-92.62	236.17	3201.02
PEG	-9552.54	-17.89	-0.19
Price/Book	55.54	2.78	1.79
Price/Cash Flow	5.65	-125.64	-133.16
Prices/Earnings	17711.79	1777.12	9.98
Price/Sales	73.97	8.91	5.12
Price/FCF	5.65	-125.64	-133.16
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-48.15	0.14	0.28
Operating Margin	-82.78	0.03	0.19
ROA	-99.33	< 0.005	0.02
ROE	0.04	< 0.005	-99.13
ROIC	0.03	< 0.005	-99.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.27	-0.06	367.42
Dividends QOQ	0.45	-1.00	121.21
EBIT QOQ	1.21	-0.88	-26.92
EPS QOQ	-0.54	-0.99	-84.53
FCF QOQ	-2.43	-0.26	89.32
Revenue QOQ	0.31	-0.32	2.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	54.42	79.99	47.00
Days Sales Outstanding (DSO)	73.24	85.91	17.30
Inventory Turnover	1.65	1.13	-31.97
Debt/Capitalization	0.45	0.59	29.60
Quick Ratio	0.52	0.35	-32.74
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3188.52	2517.43	-21.05
Cash	283.99	374.21	31.77
Capex	-86.07	-80.09	6.95
Free Cash Flow	-42.81	-55.72	-30.16
Revenue	1112.40	785.25	-29.41
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.74	0.55	-26.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.81	19.58	187.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating